Literature DB >> 24072411

Evidence of cell damages caused by circulating bubbles: high level of free mitochondrial DNA in plasma of rats.

Nicolas Vallée1, Sandrine Gaillard, André Peinnequin, Jean-Jacques Risso, Jean-Eric Blatteau.   

Abstract

Bubble formation can occur in the vascular system after diving, leading to decompression sickness (DCS). DCS signs and symptoms range from minor to death. Too often, patients are admitted to a hyperbaric center with atypical symptoms, as bubbles cannot be detected anymore. In the absence of a relevant biomarker for humans, the therapeutic management remains difficult. As circulating DNA was found in the blood of healthy humans and animals, our study was made to correlate the extracellular mitochondrial DNA (mDNA) concentration with the occurrence of clinical DCS symptoms resulting from initial bubble-induced damages. Therefore, 109 rats were subjected to decompression from a simulated 90-m sea water dive, after which, 78 rats survived (71.6%). Among the survivors, 15.6% exhibited typical DCS symptoms (DCS group), whereas the remaining 56% showed no detectable symptoms (noDCS group). Here, we report that the symptomatic rats displayed both a circulating mDNA level (DNADCS → 2.99 ± 2.62) and a bubble grade (median Spencer score = 3) higher than rats from the noDCS group (DNAnoDCS → 1.49 ± 1.27; Spencer score = 1). These higher levels could be correlated with the platelet and leukocyte consumption induced by the pathogenic decompression. Rats with no detectable bubble had lower circulating mDNA than those with higher bubble scores. We determined that in rats, a level of circulating mDNA >1.91 was highly predictive of DCS with a positive-predictive value of 87.3% and an odds ratio of 4.57. Thus circulating mDNA could become a relevant biomarker to diagnose DCS and should be investigated further to confirm its potential application in humans.

Entities:  

Keywords:  biomarker; bubble; diving; gas; nitrogen

Mesh:

Substances:

Year:  2013        PMID: 24072411     DOI: 10.1152/japplphysiol.00025.2013

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

1.  Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the "spadin" Antidepressant.

Authors:  Nicolas Vallée; Kate Lambrechts; Sébastien De Maistre; Perrine Royal; Jean Mazella; Marc Borsotto; Catherine Heurteaux; Jacques Abraini; Jean-Jacques Risso; Jean-Eric Blatteau
Journal:  Front Physiol       Date:  2016-02-16       Impact factor: 4.566

2.  Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness.

Authors:  Caroline Cosnard; Sébastien De Maistre; Jacques H Abraini; Laurent Chazalviel; Jean-Eric Blatteau; Jean-Jacques Risso; Nicolas Vallée
Journal:  Front Physiol       Date:  2017-09-05       Impact factor: 4.566

3.  Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?

Authors:  Kate Lambrechts; Sébastien de Maistre; Jacques H Abraini; Jean-Eric Blatteau; Jean-Jacques Risso; Nicolas Vallée
Journal:  Front Physiol       Date:  2018-07-11       Impact factor: 4.566

4.  Stimulating fermentation by the prolonged acceleration of gut transit protects against decompression sickness.

Authors:  Sébastien de Maistre; Nicolas Vallée; Sandrine Gaillard; Claude Duchamp; Jean-Eric Blatteau
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

5.  Cecal metabolome fingerprint in a rat model of decompression sickness with neurological disorders.

Authors:  Sébastien de Maistre; Sandrine Gaillard; Jean-Charles Martin; Simone Richard; Alain Boussuges; Sarah Rives; Anne-Virginie Desruelle; Jean-Eric Blatteau; Catherine Tardivel; Jean-Jacques Risso; Nicolas Vallée
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.